NCT03671018 · Interventional trial
A Study to Evaluate the Safety and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With Polatuzumab Vedotin in B-Cell Non-Hodgkin Lymphoma
Overall registry status Active not recruiting
Phase 1 · Phase 2
Conditions B-cell Non-Hodgkin Lymphoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory